מושבי לווין

June 3

AstraZeneca | 07:00 - 08:00

Title: TTRansforming Care in Amyloidosis

Session Agenda: TBD

Bayer + AstraZeneca | 12:30-14:00

Title: Heart and Kidney in Harmony: The Game-Changing Potential of SGLT21 & ns-MRA

Session Agenda: TBD

Medison Pharma | 12:30-14:00

Title: Optical Illusion of the PCSK9 Treatment: You Can Get Much More Than What You See

Click here to view agenda.

Pfizer Pharmaceuticals Israel | 12:30-14:00

Title: Can We Do BeTTR? Optimizing Diagnosis of Cardiac Amyloidosis in Heart Failure Patients

Session is open for medical technicians 

Session Agenda: TBD

Abbott Laboratories | 12:30-14:00

Title: When Experience Matters Most – Mitral & TriCuspid Interventions

Session Agenda: TBD

Novo Nordisk | 12:30-14:00

Title: Navigating Residual Risk in Type 2 Diabetes- Innovative Strategies For Improved Outcomes

Click here to view agenda.

June 4

Medtechnica | 12:30-14:00

Title: Intra Coronary Imaging: Expanding Hirisings to Improve Outcomes

Session Agenda: TBD

Novo Nordisk | 12:30-14:00

Title: Mending Broken Hearts with GLP-1 in Obesity Management

Click here to view agenda.

Boehringer Ingelheim Israel | June 4 | 12:30-14:00

Title: International latest's updates in Treatment for Heart Failure

Click here to view agenda.

Pfizer | June 4 | 12:30-14:00

Title: Navigating Cardiac Amyloidosis: Echocardiography and Differential Diagnosis in Focus

Session Agenda: TBD

Novartis Israel | June 4 | 12:30-14:00

Title: Heart Frontiers: Today’s Lipid Innovations, Tomorrow’s Standards

Click here to view agenda.

Edwards Lifesciences | June 4 | 12:30-14:00

Title: Latest technology updates and key considerations regarding valve therapy

Session Agenda: TBD